Skip to content

Clinical trials

Phase 2/3 Respiratory Tract Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Infections Phase: Phase 2/3 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20091
20101
20161
20181
20201
20222
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2
A. Vogel AG1
AN2 Therapeutics, Inc1
Barts & The London NHS Trust1
Laboratorios Roemmers S.A.I.C.F.1
Lallemand Pharma AG1
St. Petersburg Research Institute of Vaccines and Sera1
University of Wisconsin, Madison1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Infections11
COVID-192
Coronavirus Infections2
Infections2
Influenza, Human2
Lung Diseases2
Respiratory Tract Diseases2
Bronchial Diseases1
Bronchitis1
Bronchitis, Chronic1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.